Regulation of TGF-β Family Signaling by Inhibitory Smads
Open accessThe DOI matches its Crossref record; 210 of the 211 references it cites were found in a registry or an index.
Abstract
Inhibitory Smads (I-Smads) have conserved carboxy-terminal MH2 domains but highly divergent amino-terminal regions when compared with receptor-regulated Smads (R-Smads) and common-partner Smads (co-Smads). Smad6 preferentially inhibits Smad signaling initiated by the bone morphogenetic protein (BMP) type I receptors ALK-3 and ALK-6, whereas Smad7 inhibits both transforming growth factor β (TGF-β)- and BMP-induced Smad signaling. I-Smads also regulate some non-Smad signaling pathways. Here, we discuss the vertebrate I-Smads, their roles as inhibitors of Smad activation and regulators of receptor stability, as scaffolds for non-Smad signaling, and their possible roles in the nucleus. We also discuss the posttranslational modification of I-Smads, including phosphorylation, ubiquitylation, acetylation, and methylation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“RAB11 285, which is responsible for endosomal recycling of TGFβ receptors 286, is recruited to the cilium in a process that is mediated by the subdistal appendage protein, CEP128 287. Consequently, loss of CEP128 leads to impaired phosphorylation of R-SMADs, which in zebrafish is associated with defective organ development 287.”
From Cellular signalling by primary cilia in development, organ function and disease (2019) · cites this paper as [287]
In the citing paper
“Also, non-mutational mechanisms impair the growth inhibitory response to TGF-β. In advanced tumors, TGFBR2 or SMAD2 genes are frequently silenced by histone and DNA methylation122,123. Additionally, increased inhibitory Smad6 or Smad7 expression in various carcinomas, including PDAC, attenuates Smad signaling124,125, whereas increased expression of the Smad corepressors c-Ski or SnoN, observed in”
From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [124]
Citations
Cites
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Shi, Y., & Massagué, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00432-x · Cited by 5,857 · cited 1×
“TGF-b family ligands trigger signaling through hetero-oligomerization of two types of transmembrane receptors with intrinsic serine-threonine kinase activities: the type I and type II receptors (Shi and Massagué 2003).”
BackgroundIdentification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
Nakao, A., Afrakhte, M., Morn, A., Nakayama, T., Christian, J. L., Heuchel, R., Itoh, S., Kawabata, M., Heldin, N.-E., Heldin, C.-H., et al. (1997) · Nature · doi:10.1038/39369 · Cited by 1,809 · cited 1×
“Among the eight different Smad proteins in vertebrates, Smad6 and Smad7 are I-Smads (Hayashi et al. 1997; Imamura et al. 1997; Nakao et al. 1997; Hata et al. 1998; Souchelnytskyi et al. 1998).”
BackgroundNon-Smad pathways in TGF-β signaling
Zhang, Y. E. (2009) · Cell Research · doi:10.1038/cr.2008.328 · Cited by 1,749 · cited 1×
“…# 2017 Cold Spring Harbor Laboratory Press; all rights reserved; doi: 10.1101/cshperspect.a022095 Cite this article as Cold Spring Harb Perspect Biol 2017;9:a022095 1 tivated receptors can transmit signals independent of Smad proteins (non-Smad signaling pathways) (Zhang 2009).”
BackgroundInfluentialIdentification of a Member of the MAPKKK Family as a Potential Mediator of TGF-β Signal Transduction
Yamaguchi, K., Shirakabe, K., Shibuya, H., Irie, K., Oishi, I., Ueno, N., Taniguchi, T., Nishida, E., & Matsumoto, K. (1995) · Science · doi:10.1126/science.270.5244.2008 · Cited by 1,343 · cited 1×
“TAK1 is a MAPKKK activated in response to TGF-b, interleukin-1, and several other inducers (Yamaguchi et al. 1995; Ninomiya-Tsuji et al. 1999; Shim et al. 2005).”
BackgroundHayashi, H., Abdollah, S., Qiu, Y., Cai, J., Xu, Y.-Y., Grinnell, B. W., Richardson, M. A., Topper, J. N., Gimbrone, M. A., Wrana, J. L., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80303-7 · Cited by 1,334 · cited 1×
“Among the eight different Smad proteins in vertebrates, Smad6 and Smad7 are I-Smads (Hayashi et al. 1997; Imamura et al. 1997; Nakao et al. 1997; Hata et al. 1998; Souchelnytskyi et al. 1998).”
BackgroundSMAD proteins control DROSHA-mediated microRNA maturation
Davis, B. N., Hilyard, A. C., Lagna, G., & Hata, A. (2008) · Nature · doi:10.1038/nature07086 · Cited by 1,244 · cited 1×
“Activated Smad proteins promote the maturation of miR-21 independent of Smad4 by associating with the stem region of pri-miR-21 (Davis et al. 2008).”
BackgroundSmad7 Binds to Smurf2 to Form an E3 Ubiquitin Ligase that Targets the TGFβ Receptor for Degradation
Kavsak, P., Rasmussen, R. K., Causing, C. G., Bonni, S., Zhu, H., Thomsen, G. H., & Wrana, J. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00134-9 · Cited by 1,205 · cited 1×
“2A) (Kavsak et al. 2000; Ebisawa et al. 2001; Murakami et al. 2003).”
Ninomiya-Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J.-I., Cao, Z., & Matsumoto, K. (1999) · Nature · doi:10.1038/18465 · Cited by 1,182 · cited 1×
“TAK1 is a MAPKKK activated in response to TGF-b, interleukin-1, and several other inducers (Yamaguchi et al. 1995; Ninomiya-Tsuji et al. 1999; Shim et al. 2005).”
BackgroundFantini, M. C., Becker, C., Monteleone, G., Pallone, F., Galle, P. R., & Neurath, M. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5149 · Cited by 1,135 · cited 1×
“3), leading to enhanced TGF-b signaling and acquisition of regulatory properties by these cells, including an antiproliferative effect on CD4þ T cells (Fantini et al. 2004).”
BackgroundSmad6 inhibits signalling by the TGF-β superfamily
Imamura, T., Takase, M., Nishihara, A., Oeda, E., Hanai, J.-I., Kawabata, M., & Miyazono, K. (1997) · Nature · doi:10.1038/39355 · Cited by 1,029 · cited 1×
“Among the eight different Smad proteins in vertebrates, Smad6 and Smad7 are I-Smads (Hayashi et al. 1997; Imamura et al. 1997; Nakao et al. 1997; Hata et al. 1998; Souchelnytskyi et al. 1998).”
BackgroundSelf-citation
Research works printed but not linked: 1
- 10.1172/jci200112367 · doi:10.1172/jci200112367 · Paper page
Cited by
Items 201–300 of 463
Gucht, I. V., Meester, J., Bento, J. R., Bastiaansen, M., Bastianen, J., Luyckx, I., Heuvel, L. J. F. V. D., Neutel, C. H. G., Guns, P., Vermont, M., et al. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.04.019 · Cited by 24
Zhang, S., Wang, N., Ma, Q., Fan, F., & Ma, X. (2021) · Cell Biology International · doi:10.1002/cbin.11707 · Cited by 25
VGLL3 activates inflammatory responses by inducing interleukin‐1α secretion
Takakura, Y., Hori, N., Terada, N., Machida, M., Yamaguchi, N., Takano, H., & Yamaguchi, N. (2021) · The FASEB Journal · doi:10.1096/fj.202100679rr · Cited by 24
Wang, Y., Han, T., Guo, R., Song, P., Liu, Y., Wu, Z., Ai, J., & Shen, C. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.850364 · Cited by 27
Nataf, S., Guillen, M., & Pays, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235934 · Cited by 24
The Role of Bone Morphogenetic Protein 4 in Ovarian Function and Diseases
Yang, D., Yang, X., Dai, F., Wang, Y., Yang, Y., Hu, M. S., & Cheng, Y. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00600-8 · Cited by 25
Peptides Derived from Growth Factors to Treat Alzheimer’s Disease
Gascon, S., Jann, J., Langlois-Blais, C., Plourde, M., Lavoie, C. L., & Faucheux, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116071 · Cited by 25
New genetic drivers in hemorrhagic hereditary telangiectasia
Cerdà, P., Castillo, S. D., Aguilera, C., Iriarte, A., Rocamora, J. L. S., Martinez‐Larrinaga, A., Viñals, F., Graupera, M., & Riera-Mestre, A. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.08.024 · Cited by 23
The ZDHHC13/ZDHHC17 subfamily: From biological functions to therapeutic targets of diseases
Zhang, Y., Fan, S., He, L., & Li, L. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107418 · Cited by 23
Birkou, M., Chasapis, C. T., Marousis, K. D., Loutsidou, A. K., Bentrop, D., Lelli, M., Herrmann, T., Carthy, J. M., Episkopou, V., & Spyroulias, G. A. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.06.012 · Cited by 23
Xu, S., & Wu, X.-J. (2018) · Bioscience Reports · doi:10.1042/bsr20180921 · Cited by 22
Su, Y., Shi, D., Xia, G., Liu, Y., Xu, L., Dao, L., Lu, X., Shen, C., & Xu, C. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.91396 · Cited by 22
Primary Ciliary Signaling in the Skin—Contribution to Wound Healing and Scarring
Hosio, M., Jaks, V., Lagus, H., Vuola, J., Ogawa, R., & Kankuri, E. M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.578384 · Cited by 22
“…of TGF-β signaling, SMAD7, and the E3 ubiquitin-protein ligase SMURF1 also localize to the base of the primary cilium and have been suggested to thereby limit excessive TGF-β/BMP signaling (Clement et al., 2013; Heldin and Moustakas, 2016; Miyazawa and Miyazono, 2017; Koefoed et al., 2018).”
BackgroundMašlanková, J., Večurkovská, I., Rabajdová, M., Kaťuchová, J., Kička, M., Gayova, M., & Katuch, V. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i33.4744 · Cited by 23
LIPUS as a potential strategy for periodontitis treatment: A review of the mechanisms
Aimaijiang, M., Liu, Y., Zhang, Z., Qin, Q., Liu, M., abulikemu, P., Liu, L., & Zhou, Y. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1018012 · Cited by 23
Yang, H., Guo, F.-Y., Lin, Y.-C., Wu, Y., Nan, J., Jin, C. H., & Lian, L. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106723 · Cited by 21
Structural basis for inhibitory effects of Smad7 on TGF-β family signaling
Murayama, K., Kato-Murayama, M., Itoh, Y., Miyazono, K., Miyazawa, K., & Shirouzu, M. (2020) · Journal of Structural Biology · doi:10.1016/j.jsb.2020.107661 · Cited by 21
Self-citationSong, Y., Pan, S., Li, K., Chen, X., Wang, Z. P., & Zhu, X. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.06.001 · Cited by 25
Borisenko, I., Bolshakov, F. V., Ereskovsky, A. V., & Lavrov, A. (2021) · Genes · doi:10.3390/genes12060944 · Cited by 26
“Type I and Type II receptors in H. dujardinii both demonstrate a high level of sequence divergence, although SMADs clearly fall into SMAD1/5/8, SMAD2/3, and SMAD4 families.”
BackgroundInfluentialBasu, B., & Ghosh, M. K. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119261 · Cited by 22
Non-coding RNAs regulate the BMP/Smad pathway during osteogenic differentiation of stem cells
Zhang, Q., Long, Y., Jin, L., Li, C., & Long, J. (2023) · Acta Histochemica · doi:10.1016/j.acthis.2023.151998 · Cited by 21
Cai, A., Meng, Y., Zhou, H., Cai, H., Shao, X., Wang, Q., Xu, Y., Zhou, Y., Zhou, W., Chen, L., et al. (2024) · Advanced Science · doi:10.1002/advs.202404151 · Cited by 20
Uterine fibroids: current research on novel drug targets and innovative therapeutic strategies
Ciebiera, M., Kociuba, J., Ali, M. K., Madueke-Laveaux, O. S., Yang, Q., Bączkowska, M., Włodarczyk, M., Żeber‐Lubecka, N., Zarychta, E., Corachán, A., et al. (2024) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2024.2390094 · Cited by 23
“In UFs, these proteins regulate cell proliferation and ECM formation at the transcriptional level [28,48].”
Kandhaya‐Pillai, R., Hou, D., Zhang, J., Yang, X., Compoginis, G., Mori, T., Tchkonia, T., Martin, G. M., Hisama, F. M., Kirkland, J. L., et al. (2021) · GeroScience · doi:10.1007/s11357-020-00318-6 · Cited by 21
Zhong, J., Kang, Q., Cao, Y., He, B., Zhao, P., Gou, Y., Luo, Y., He, T., & Fan, J. (2021) · PubMed · Cited by 21
ANXA10 promotes melanoma metastasis by suppressing E3 ligase TRIM41-directed PKD1 degradation
Zhang, X., Hu, Z., Wang, X., Li, L., Zhu, B., Lin, X., Zhang, J., & Hua, Z. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.07.033 · Cited by 20
Bone morphogenetic protein and blood vessels: new insights into endothelial cell junction regulation
Bautch, V. L. (2019) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000492 · Cited by 20
“Another intracellular inhibitory SMAD, SMAD7, can negatively regulate both BMP and TGFb signaling in diverse cell types [10], although its role in the vasculature is not well studied.”
BackgroundHanafy, N. A. N., Fabregat, I., Leporatti, S., & El-Kemary, M. A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12050421 · Cited by 20
Shen, Y., Jiang, B., Zhang, C., Wu, Q., Li, L., & Jiang, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311010 · Cited by 19
“According to their functions, SMAD proteins can be divided into three subfamilies: receptor-activated SMAD (R-SMAD), common pathway SMAD (Co-SMAD), and suppressed SMAD (I-SMAD) [44,55].”
BackgroundBiallelic variants in SMAD6 are associated with a complex cardiovascular phenotype
Kloth, K., Bierhals, T., Johannsen, J., Harms, F. L., Juusola, J., Johnson, M. C., Grange, D. K., & Kutsche, K. (2019) · Human Genetics · doi:10.1007/s00439-019-02011-x · Cited by 19
TGFβ as a gatekeeper of BMP action in the developing growth plate
Wang, W., Rigueur, D., & Lyons, K. M. (2020) · Bone · doi:10.1016/j.bone.2020.115439 · Cited by 21
Liang, H., Wang, Q., Wang, D., Zheng, H., Kalvakolanu, D. V., Lu, H., Wen, N., Chen, X., Xu, L., Ren, J., et al. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114118 · Cited by 19
Lin, H., Shi, F., Jiang, S., Wang, Y., Zou, J., Ying, Y., Huang, D., Luo, L., Yan, X., & Luo, Z. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16076 · Cited by 19
Li, Y., Wu, J., Tian, Y., Zhu, Q., Ge, Y., Yu, H., Huang, J., Li, H., Zhang, J., Zhang, L., et al. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.01.013 · Cited by 19
Manipulating TGF-β signaling to optimize immunotherapy for cervical cancer
Yin, S., Cui, H., Qin, S., & Yu, S. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115355 · Cited by 19
Bone morphogenetic proteins and inner ear development
Ma, J., You, D., Li, W., Lü, X., Sun, S., & Li, H. (2018) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1800084 · Cited by 19
A narrative review of the relationship between TGF-β signaling and gynecological malignant tumor
Luo, F., Huang, Y., Li, Y., Zhao, X., Xie, Y., Zhang, Q., Mei, J., & Liu, X. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-4879 · Cited by 18
“Furthermore, SMAD7 can antagonize the binding of SMAD2/3 and TGFβR-I receptor through its MH2 domain and interfere with SMAD2/3/4 complex (37,38), thereby preventing TGFβ-mediated signal propagation (Figure 1).”
BackgroundEvolution and Diversity of TGF-β Pathways are Linked with Novel Developmental and Behavioral Traits
Lo, W., Roca, M., Dardiry, M., Mackie, M., Eberhardt, G., Witte, H., Hong, R. L., Sommer, R. J., & Lightfoot, J. W. (2022) · Molecular Biology and Evolution · doi:10.1093/molbev/msac252 · Cited by 18
“In other species, I-Smads are known to regulate both Smad and non-Smad pathways in order to adjust TGF-β signaling levels and are associated with numerous clinical diseases in humans (Miyazawa and Miyazono 2017).”
Zhu, W.-H., Chen, J., Huang, R., Zhang, Y., Huang, Z.-X., Pang, X., Hu, B., Yang, Y., & Li, X. (2023) · Theranostics · doi:10.7150/thno.82907 · Cited by 18
YAP in development and disease: Navigating the regulatory landscape from retina to brain
Zhao, Y., Sun, B., Fu, X., Zuo, Z., Qin, H., & Yao, K. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116703 · Cited by 18
Structure, unique biological properties, and mechanisms of action of transforming growth factor β
Zelisko, N., Lesyk, R., & Стойка, Р. С. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107611 · Cited by 19
Cao, B., Zhang, K., Zuo, R., Kang, Z., Lin, J., Kang, Z., Luo, D., Chai, Y., Xu, J., Kang, Q., et al. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002312 · Cited by 19
“On the contrary, repressive SMADs such as Smad6 and Smad7 antagonize the activation of receptor-regulated SMADs [45] .”
Calycosin and kidney health: a molecular perspective on its protective mechanisms
Dalal, D., Singh, L., & Singh, A. (2025) · Pharmacological Reports · doi:10.1007/s43440-025-00728-3 · Cited by 18
“…mediators, transforming growth factor-beta (TGF-β) plays a key role in kidney fibrosis by activating suppressors of mothers against decapentaplegic-2/3 (SMAD-2/3) via TGF-β receptor type I and II (TβRII/TβRI) signaling, leading to the transcription of genes linked to kidney fibrosis [ 14, 15].”
Regulation of bone morphogenetic protein 4 on epithelial tissue
Shen, S., Wang, S., He, Y., Hu, H., Yao, B., & Zhang, Y. (2020) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-019-00537-3 · Cited by 18
Understanding Transcriptional Networks Regulating Initiation of Cutaneous Wound Healing.
Boudra, R., & Ramsey, M. R. (2020) · The Yale Journal of Biology and Medicine · Cited by 24
Genetics of renovascular hypertension in children
Viering, D. H. H. M., Chan, M., Hoogenboom, L. A., Iancu, D., de Baaij, J. H. F., Tullus, K., Kleta, R., & Böckenhauer, D. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002491 · Cited by 18
“The SMAD6 protein is an inhibitory factor in the transforming growth factor beta (TGFB) pathway [27].”
BackgroundGinkgolic acid improves bleomycin‐induced pulmonary fibrosis by inhibiting SMAD4 SUMOylation
Yu, L., Bian, X., Zhang, C., Wu, Z., Huang, N., Yang, J., Jin, W., Feng, Z., Li, D., Huo, X., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/8002566 · Cited by 19
“However, it has been found that SMAD2 and SMAD3 are involved in TGF-β signal transduc tion in a rat model of IPF [32], while SMAD6 and SMAD7 inhibited this TGF-β activity [33].”
Emerging biologics for the treatment of pulmonary arterial hypertension
Hye, T., Hossain, M. R., Saha, D., Foyez, T., & Ahsan, F. (2023) · Journal of drug targeting · doi:10.1080/1061186x.2023.2199351 · Cited by 20
Mörsdorf, D., Knabl, P., & Genikhovich, G. (2024) · Development Genes and Evolution · doi:10.1007/s00427-024-00714-4 · Cited by 17
Li, X., Wang, X., Wang, Y., Liang, Q., Li, Y., Chen, Y.-W., & Ming, H. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114858 · Cited by 21
The Integrator complex desensitizes cellular response to TGF-β/BMP signaling
Liu, S., Baeg, G. H., Yang, Y., Goh, F. G., Bao, H., Wagner, E. J., Yang, X., & Cai, Y. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112007 · Cited by 20
Ablation of the mammalian lectin galectin‐8 induces bone defects in mice
Vinik, Y., Shatz‐Azoulay, H., Hiram‐Bab, S., Kandel, L., Gabet, Y., Rivkin, G., & Zick, Y. (2017) · The FASEB Journal · doi:10.1096/fj.201700716r · Cited by 17
“These included the BMP targets ID1, ID2, ID3 (42), Smad6 and Smad7 (43), and a number of others.”
BackgroundRegulation of transforming growth factor-β signalling by SUMOylation and its role in fibrosis
Wang, X., Liu, T., Huang, Y., Dai, Y., & Lin, H. (2021) · Open Biology · doi:10.1098/rsob.210043 · Cited by 17
“In addition, I-Smads act as inhibitors by recruiting the E3 ubiquitin ligase Smad ubiquitination regulatory factor 2 (Smurf2) to degrade activated TβRI via ubiquitination [5].”
BackgroundInfluentialLau, Y. C., Li, Y., & Kido, T. (2018) · Asian Journal of Andrology · doi:10.4103/aja.aja_43_18 · Cited by 19
Phosphoinositide-binding activity of Smad2 is essential for its function in TGF-β signaling
Buwaneka, P., Ralko, A. A., Gorai, S., Pham, H. T. T., & Cho, W. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101303 · Cited by 17
“We first determined by the SPR analysis the PtdInsP selectivity of Smad2 using 1-Palmitoyl-2-oleoyl-sn-glycero-3phosphocholine (POPC)/1-palmitoyl-2-oleoyl-sn-glycero-3phosphoserine (POPS)/PtdInsP (77:20:3 in molar ratio) LUVs coated onto the L1 sensor chip, with a focus on its relative binding affinity for PI(4,5)P2 v…”
BackgroundMethodInfluentialThe Roles of SNHG Family in Osteoblast Differentiation
Tan, A., & Zheng, Y. (2022) · Genes · doi:10.3390/genes13122268 · Cited by 16
Roles of TGF‑β signalling pathway‑related lncRNAs in cancer (Review)
Hu, Z., Liu, Y., Liu, M., Zhang, Y., & Wang, C. (2023) · Oncology Letters · doi:10.3892/ol.2023.13693 · Cited by 16
“Firstly, SMAD6/7 competes with R‐SMADs for recruitment to type I receptors and prevents activation of R‐SMADs by phosphorylation (36).”
Roles of Vascular Smooth Muscle Cells in Atherosclerotic Calcification
Woo, S., Kim, D.-Y., & Choi, J. (2023) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2023.12.2.106 · Cited by 18
Targeting the deubiquitinase USP2 for malignant tumor therapy (Review)
Zhang, S., Guo, Y., Zhang, S., Wang, Z. W., Zhang, Y., & Zuo, S. (2023) · Oncology Reports · doi:10.3892/or.2023.8613 · Cited by 15
“Receptor kinases activate the intracellular signaling protein SMAD to form heterologous protein complexes that are trans‑ ferred to the nucleus, where they regulate the transcription of EMT‑related genes, such as Snail, Slug (zinc‑finger proteins), Twist, N‑cadherin and E‑cadherin (78).”
BackgroundWardman, R., Keleş, M., Pachkiv, I., Hemanna, S., Grein, S., Schwarz, J., Stein, F., Ola, R., Dobreva, G. D., Hentze, M. W., et al. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.319925 · Cited by 15
“For instance, we found that on TGF-β stimulation hnRNP H1 binds with increased affinity to mRNAs encoding for Smad6 , a canonical antagonist of TGF-β signaling, 38,39 and Col1a1, a classical component of the extracellular matrix associated with fibrosis and EndoMA.”
Yin, X., Lin, L., Fang, F., Zhang, B., & Shen, C. (2023) · Stem Cells International · doi:10.1155/2023/6500831 · Cited by 17
“It inhibits downstream gene transcription by inhibiting the phosphorylation of Smad2/3 by TGF-β 1 and interfering with the interactions between receptors and other Smad proteins [103].”
BackgroundHung, C.-Y., Hsueh, T.-Y., Rethi, L., Lu, H., & Chuang, A. E.-Y. (2025) · Journal of Materials Chemistry B · doi:10.1039/d4tb01769b · Cited by 15
Chromatin accessibility dynamics of Chlamydia-infected epithelial cells
Hayward, R. J., Marsh, J. W., Humphrys, M. S., Huston, W. M., & Myers, G. S. A. (2020) · Epigenetics & Chromatin · doi:10.1186/s13072-020-00368-2 · Cited by 16
SMAD4 contributes to chondrocyte and osteocyte development
Pakravan, K., Razmara, E., Hussen, B. M., Sattarikia, F., Sadeghizadeh, M., & Babashah, S. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17080 · Cited by 16
Huang, W., Tao, Y., Zhang, X., & Zhang, X. (2022) · Toxicology in Vitro · doi:10.1016/j.tiv.2021.105303 · Cited by 15
Metwaly, H. A., El‐Eraky, A. M., Ibrahim, E. E., Kandil, K. K., El‐Sayed, M. A., El‐Tabakh, N. M., Motawea, A. M., Ali, H. A., Jabban, M. Z., Mahmoud, M. E.-M., et al. (2022) · Cell Biochemistry and Function · doi:10.1002/cbf.3686 · Cited by 15
“R-docking and phosphorylation, diverting them to proteasome degradation.(53) TGF-β1 has been recognized as an attractive target for therapeutic interventions, as the Smad-dependent signalling pathway is essential to the pathogenesis of CKD.”
BackgroundMechanisms and clinical significance of TGF-β in hepatocellular cancer progression
Zaidi, S., Gough, N. R., & Mishra, L. (2022) · Advances in cancer research · doi:10.1016/bs.acr.2022.02.002 · Cited by 15
Hepatic Smad7 overexpression causes severe iron overload in mice
Lai, D., Feng, T., Hammad, S., Werle, J., Maass, T., Teufel, A., Muckenthaler, M. U., Dooley, S., & Spasić, M. V. (2017) · Blood · doi:10.1182/blood-2017-07-796797 · Cited by 16
Zhang, Z., Liu, C., Chen, B., Tang, W., Liu, Z., Cao, W., & Li, X. (2020) · Burns · doi:10.1016/j.burns.2020.12.017 · Cited by 15
He, Z., Li, Y., Feng, G., Yuan, X., Lu, Z., Dai, M., Hu, Y., Zhang, Y., Zhou, Q., & Li, W. (2022) · Advanced Science · doi:10.1002/advs.202104682 · Cited by 16
Mendoza, F. A., & Jiménez, S. A. (2021) · Rheumatology · doi:10.1093/rheumatology/keab762 · Cited by 16
Ethanol Effects on Early Developmental Stages Studied Using the Zebrafish
Manikandan, P., Sarmah, S., & Marrs, J. A. (2022) · Biomedicines · doi:10.3390/biomedicines10102555 · Cited by 18
Inhibition of TGF-β signaling, invasion, and growth of cutaneous squamous cell carcinoma by PLX8394
Siljamäki, E., Riihilä, P., Suwal, U., Nissinen, L. M., Rappu, P., Kallajoki, M. A., Kähäri, V., & Heino, J. (2023) · Oncogene · doi:10.1038/s41388-023-02863-8 · Cited by 14
“Thus, PLX8394 does not appear to be a universal inhibitor of p38 pathway.”
BackgroundPeng, C., Wang, Y., Guo, Y., Li, J., Liu, F., Fu, Y., Yu, Y., Chengxin, Z., Fu, J., & Han, F. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118491 · Cited by 14
Woodhams, L., Sim, T. F., Chalmers, L., Yeap, B. B., GREEN, D. J., Schlaich, M. P., Schultz, C. J., & Hillis, G. S. (2021) · PeerJ · doi:10.7717/peerj.11070 · Cited by 16
Hori, N., Takakura, Y., Sugino, A., Iwasawa, S., Nomizo, K., Yamaguchi, N., Takano, H., & Yamaguchi, N. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17279 · Cited by 14
Chi, C., Liu, X., Hou, F., Yu, X., Li, C., Cui, L., Liu, R., & Yin, C. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2119-7 · Cited by 14
Ikeda, J., Shimojima, Y., Usami, Y., Ueno, K., Kishida, D., & Sekijima, Y. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-04971-2 · Cited by 14
Huang, M. J., Cheng, Y., Zeng, J., Su, X., & Liu, H. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26843 · Cited by 13
“It is well known that Smad6/7 are inhibitors for BMP/Smad signal.(46) Indeed, it has been proved the impact of Smad6/7 as important molecular targets for the negative control of bone formation.”
BackgroundArginine methylation of R81 in Smad6 confines BMP-induced Smad1 signaling
Wu, J., Chen, X., Sehgal, P., Zhang, T., Jackson‐Weaver, O., Gou, Y., Bautch, V. L., Frenkel, B., Sun, H., & Xu, J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100496 · Cited by 13
“Among BMP target genes is Smad6, which encodes an inhibitory Smad that restrains the BMP response at multiple levels (3).”
BackgroundTranscriptome Profiling of Embryonic Retinal Pigment Epithelium Reprogramming
Tangeman, J. A., Luz-Madrigal, A., Sreeskandarajan, S., Grajales‐Esquivel, E., Liu, L., Liang, C., Tsonis, P. A., & Rio‐Tsonis, K. D. (2021) · Genes · doi:10.3390/genes12060840 · Cited by 14
“Importantly, SMAD6, an inhibitory signal transducer of BMP and TGF-β signaling, was also up-regulated (Supplementary File S2) [101].”
BackgroundTsai, W., Yu, T., Chang, G., Chang, H., Lin, L., Lin, M., & Pang, J. S. (2021) · The American Journal of Sports Medicine · doi:10.1177/03635465211030295 · Cited by 13
Shan, Y., Chen, Y., Brkić, J., Fournier, L., Hai-ying, M., & Peng, C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.842587 · Cited by 13
“SMAD7 is known to block the activation of R-SMADs by TGFb, activin, and bone morphogenetic proteins (BMPs), while SMAD6 preferentially inhibits BMP-induced SMAD1 activation (45, 46).”
BackgroundZieba, J. T., Forlenza, K. N., Heard, K. J., Martin, J. H., Bosakova, M. K., Cohn, D. H., Robertson, S. P., Krejčí, P., & Krakow, D. (2022) · Bone Research · doi:10.1038/s41413-022-00200-5 · Cited by 13
Zou, J., Zhou, X., Chen, X., Ma, Y., & Yu, R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.849832 · Cited by 15
Fan, T. T., Chu, X., Liu, H., Liu, Y., Wang, L., Tian, H., Li, C., & He, J. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01612-3 · Cited by 13
“The protein level of SMAD6, an inhibitory factor of the TGF-β pathway, 31 had no signi fi cant change after CFP1 knockdown although SMAD6 transcription decreased in qPCR and RNA-seq (Fig.”
BMP/TGF‐β signaling as a modulator of neurodegeneration in ALS
Russo, K., & Wharton, K. A. (2021) · Developmental Dynamics · doi:10.1002/dvdy.333 · Cited by 14
“Phosphorylated RSmads, the effector in Smad-dependent signaling, are generally distinct between the two branches with pSmad1/5/8 mediating signaling induced by BMP and growth differentiation factor (GDF) ligands, and pSmad2/3 mediating signaling initiated by TGF-β, Activin, and Nodal ligands,(1) with inhibitory I-Smad…”
BackgroundYap, Z. L., Seet, L., Chu, S. W. L., Toh, L. Z., Ibrahim, F. I., & Wong, T. T. L. (2021) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2020-318691 · Cited by 13
Estrogen reverses nicotine‐induced inflammation in chondrocytes via reducing the degradation of ECM
Peng, X., Qiao, Z., Wang, Y., Li, H., Xie, Y., Xin, M., Qiao, Z., & Wang, Z. (2019) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13476 · Cited by 13
Transforming growth factor beta signaling: The master sculptor of fingers
Lorda-Diez, C. I., Duarte‐Olivenza, C., Hurlé, J. M., & Montero, J. A. (2021) · Developmental Dynamics · doi:10.1002/dvdy.349 · Cited by 13
“SMADs are classified as follows on the basis of their functions: the receptor-regulated SMADs (R-SMADs), including SMAD 1, 2, 3, 5, and 8, which are specifically phosphorylated by activated type I receptors(23); common-mediator SMAD 4 (Co-SMAD4), which binds the activated R-SMADs mediating nuclear translocation of the…”
BackgroundAirway stenosis: classification, pathogenesis, and clinical management
Zhao, P., Jiang, Z., Li, X., Ainiwaer, M., Li, L., Wang, D., Fan, L., Chen, F., & Liu, J. (2025) · MedComm · doi:10.1002/mco2.70076 · Cited by 14
Azadi, A. S., Carmichael, R. E., Kovacs, W. J., Koster, J., Kors, S., Waterham, H. R., & Schrader, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.577637 · Cited by 12
Kulikauskas, M. R., Oatley, M., Yu, T., Liu, Z., Matsumura, L., Kidder, E., Ruter, D. L., & Bautch, V. L. (2023) · Development · doi:10.1242/dev.201811 · Cited by 13
CtBP represses Dpp-dependent Mad activation during Drosophila eye development
Eusébio, N., Tavares, L., & Pereira, P. S. (2018) · Developmental Biology · doi:10.1016/j.ydbio.2018.07.018 · Cited by 12
The biology of bone morphogenetic protein signaling pathway in cerebrovascular system
Tang, H., Zhang, X., Xue, G., Xu, F. L., Wang, Q., Yang, P., Hong, B., Xu, Y., Huang, Q., Liu, J., et al. (2021) · Chinese Neurosurgical Journal · doi:10.1186/s41016-021-00254-0 · Cited by 12
Priolo, M., Radio, F. C., Pizzi, S., Pintomalli, L., Pantaleoni, F., Mancini, C., Cordeddu, V., Africa, E., Mammì, C., Dallapiccola, B., et al. (2021) · Genes · doi:10.3390/genes12071009 · Cited by 11
“Smad proteins are intracellular mediators required for regulation of intracellular signal transduction by members of the TGFβ/BMP superfamily [13].”
BackgroundInfluentialZhang, Y., Zhou, S.-Q., Xie, M.-M., jiang, Q.-L., Yang, N., Wu, R., Zhou, J., & Xu, X.-R. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2022.109335 · Cited by 11
Wang, L., Fan, J., Yang, T., Shen, J., Wang, L., & Ge, W. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149387 · Cited by 11
Lv, L., Zhang, D., Hua, P., & Yang, S. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118760 · Cited by 11
At the Crux of Joint Crosstalk: TGFβ Signaling in the Synovial Joint
Bailey, K. N., & Alliston, T. N. (2022) · Current Rheumatology Reports · doi:10.1007/s11926-022-01074-6 · Cited by 11
Metadata
- Authors
- Miyazawa, K., & Miyazono, K.
- Affiliations
- University of Yamanashi (JP)
- The University of Tokyo (JP)
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2016-12-05
- Volume
- 9
- Issue
- 3
- Pages
- a022095
- ISSN
- 1943-0264 (ISSN-L)
- PMC
- PMC5334261
- OpenAlex
- W2560615789
- Cited by
- 439
- References
- 211
- Citations by year
- 2026: 25 · 2025: 32 · 2024: 43 · 2023: 56 · 2022: 61 · 2021: 78 · 2020: 56 · 2019: 33 · 2018: 32 · 2017: 19 · 2016: 2
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (15H05774)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Keywords
- inhibitory Smads, Smad6, Smad7, TGF-beta signaling, BMP signaling, Smad activation, receptor stability, non-Smad signaling, post-translational modification, phosphorylation, ubiquitination, acetylation, methylation
- MeSH terms
- Animals, Humans, Protein Conformation, Protein Processing, Post-Translational, Signal Transduction, Transforming Growth Factor beta, Smad Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.